Reactions during an injection or infusion are common, alarming, and frequently not allergy at all. A large proportion are rate-related - caused by giving the drug too quickly rather than by the immune system - and they resolve by slowing the infusion and continuing. Getting that distinction right matters, because a reaction recorded as an allergy closes off a treatment the person could have carried on with.
Three different things
True allergy - an immune reaction. Weals, swelling of the face or throat, wheeze, a drop in blood pressure or collapse, usually within minutes. This is anaphylaxis and it is treated with adrenaline.
Infusion reaction - flushing, itching, a rash, fever, chills, aching, headache, nausea, breathlessness or a change in blood pressure. It is driven by release of inflammatory mediators rather than by antibodies, and it is typically rate-related.
Injection site reaction - redness, swelling, itching or a lump confined to where the injection went in, with no features elsewhere.
The distinction turns on what happens beyond the site, and on whether breathing and blood pressure are involved.
Vancomycin: the classic example
Worth naming because it is so often mislabelled.
Vancomycin given too fast causes flushing of the face, neck and upper body, sometimes with itching and a fall in blood pressure.
It is a direct histamine release caused by the infusion rate, not an allergy. It is managed by stopping, giving an antihistamine, and restarting more slowly - and the drug can continue to be used.
Recording it as "allergic to vancomycin" removes an important antibiotic unnecessarily.
See vancomycin.
Biologics and monoclonal antibodies
Infusion reactions are well recognised with these, and follow a pattern.
They are commonest with the first or second infusion, and become less likely as treatment continues.
They typically occur during the infusion or shortly after, which is why you are observed.
Premedication - an antihistamine, paracetamol and sometimes a steroid - is frequently given beforehand to reduce them.
Management is usually to pause, treat the symptoms, and restart at a slower rate rather than abandoning the drug.
A delayed reaction days later is different and should be reported.
See biologics.
Injection site reactions
Very common with subcutaneous biologics and insulin, and usually harmless.
Redness, swelling and itching at the site, settling over days and becoming less frequent with continued treatment.
Things that help: letting a refrigerated pen reach room temperature first, rotating sites, not injecting into an area that is inflamed, and a cold compress afterwards. Some products sting because of a citrate buffer, and a citrate-free version may exist.
Report a site reaction that is spreading, increasingly painful, warm with fever, or accompanied by symptoms elsewhere - that may be infection or a genuine allergic reaction.
Repeated injection into the same area causes lipohypertrophy - lumpy tissue that absorbs insulin unpredictably and causes erratic control.
See injecting yourself at home.
Warning signs during any infusion
Tell the nurse immediately about:
- Swelling of the lips, tongue or throat, or difficulty breathing or swallowing
- Tightness in the chest or wheeze
- Widespread weals or itching
- Feeling faint, or a sense that something is badly wrong
- Back or abdominal pain
- Fever or shaking chills
Do not wait to see whether it passes. Infusions are given in monitored settings precisely so these can be caught early, and stopping the infusion is the first treatment.
See anaphylaxis.
Get it recorded accurately
The most useful thing afterwards.
Ask for the record to state what actually happened, how far into the infusion, at what rate, what treatment was given, and whether the infusion was completed.
"Reaction to infusion, rate-related, completed at slower rate" is a record someone can act on. "Allergic to X" is not, and it may be wrong.
A true anaphylactic reaction should be recorded emphatically, reported through the Yellow Card scheme, and followed by referral to an allergy service - testing identifies both the cause and, importantly, what remains safe.
See allergy alerts on your record and drug allergy testing.
Before your next one
A reaction at one infusion changes what happens at the next, and that needs arranging in advance rather than on the day.
Ask what premedication will be given, what rate will be used, and how long you will be observed. Bring a note of what happened last time, including how far into the infusion it began - that detail determines the plan and is frequently not in the record in usable form.
Carrying on afterwards
Most people who have an infusion reaction continue the treatment, with premedication and a slower rate.
Where a true allergy is confirmed and no alternative exists, desensitisation may be possible under specialist supervision.
See taking a medicine you react to.
See also Reacting to Dressings and Antiseptics, and the Side Effects section for more on side effects and safety.